UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.62-67

2015

Volltextzugriff (PDF)

CAR T in patients with large B‐cell lymphoma not fit for autologous transplant

British journal of haematology, 2023-07, Vol.202 (1), p.65-73

2023

Volltextzugriff (PDF)

Effective Use of Oral Ribavirin for Respiratory Syncytial Viral Infections in Allogeneic Haematopoietic Stem Cell Transplant Recipients

The Journal of hospital infection, 2017-02, Vol.95 (2), p.214-217

2017

Volltextzugriff (PDF)

Chimeric antigen receptor T-cell therapy in adults: management of toxicities and implications for critical care

BJA education, 2022-09, Vol.22 (9), p.330-333

2022

Volltextzugriff (PDF)

Quantum dots light up pathology

The Journal of pathology, 2008-11, Vol.216 (3), p.275-285

2008

Volltextzugriff (PDF)

OUTCOME OF LARGE B‐CELL LYMPHOMA PATIENTS FAILING CD19 TARGETED CAR‐T THERAPY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

S261: SAFETY AND PRELIMINARY EFFICACY FINDINGS OF AUTO4, A TRBC1‐TARGETTING CAR, IN RELAPSED/REFRACTORY TRBC1 POSITIVE SELECTED T CELL NON‐HODGKIN LYMPHOMA

HemaSphere, 2022-06, Vol.6, p.162-163

2022

Volltextzugriff (PDF)

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.82-86

2015

Volltextzugriff (PDF)

Compassion as a mediator between stressful events and perceived stress in Greek students

Psychiatrikē, 2016-04, Vol.27 (2), p.89-97

2016

Volltextzugriff (PDF)

Compassion as a mediator between stressful events and perceived stress in Greek students

Psychiatrikē, 2016-04, Vol.27 (2), p.89-97

2016

Volltextzugriff (PDF)

Lenalidomide for heavily pretreated relapsed/refractory myeloma cohort in northwest United Kingdom (UK) - efficacy & tolerability: high response & low second malignancy rates

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e302-e303

2015

Volltextzugriff (PDF)

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

Leukemia, 2024-07

2024

Volltextzugriff (PDF)

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

Blood, 2018-09, Vol.132 (13), p.1452-1454

2018

Volltextzugriff (PDF)

Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S130-S130

2021

Volltextzugriff (PDF)

Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction

Journal of clinical pathology, 2006-10, Vol.59 (10), p.1059-1065

2006

Volltextzugriff (PDF)

890MO Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR.T cell, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL

Annals of oncology, 2020-09, Vol.31, p.S651-S651

2020

Volltextzugriff (PDF)

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

Haematologica (Roma), 2010-06, Vol.95 (6), p.989-995

2010

Volltextzugriff (PDF)

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Clinical lymphoma, myeloma and leukemia, 2020-10, Vol.20 (10), p.e629-e644

2020

Volltextzugriff (PDF)

Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies

Biochemical and biophysical research communications, 2006-09, Vol.348 (2), p.628-636

2006

Volltextzugriff (PDF)

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1259-1261

2016

Volltextzugriff (PDF)

Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder

British journal of haematology, 2004-10, Vol.127 (2), p.209-213

2004

Volltextzugriff (PDF)

Detection of IDH1 R132H mutation in acute myeloid leukemia by mutation-specific immunohistochemistry

Applied immunohistochemistry & molecular morphology, 2012-01, Vol.20 (1), p.37

2012

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party

Biology of blood and marrow transplantation, 2019-10, Vol.25 (10), p.2008-2016

2019

Volltextzugriff (PDF)

Immune reconstitution more than one year after allogeneic haematopoietic stem cell transplantation.(Early side effects/Late effects and quality life)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S178

2009

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(52)

Sprache

Englisch
(51)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(28)
Female
(21)
Hematology
(20)
Male
(19)
Middle Aged
(17)
Adult
(15)
Aged
(14)
Hematopoietic Stem Cell Transplantation
(10)
Oncology
(9)
Adolescent
(8)
Immunology
(8)
Transplantation
(8)
Stem Cell Transplantation
(7)
Young Adult
(7)
Retrospective Studies
(6)
Biophysics
(5)
Bone Marrow
(5)
Follow-Up Studies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent

CAR T in patients with large B‐cell lymphoma not fit for autologous transplant

Effective Use of Oral Ribavirin for Respiratory Syncytial Viral Infections in Allogeneic Haematopoietic Stem Cell Transplant Recipients

Chimeric antigen receptor T-cell therapy in adults: management of toxicities and implications for critical care

Quantum dots light up pathology

OUTCOME OF LARGE B‐CELL LYMPHOMA PATIENTS FAILING CD19 TARGETED CAR‐T THERAPY

S261: SAFETY AND PRELIMINARY EFFICACY FINDINGS OF AUTO4, A TRBC1‐TARGETTING CAR, IN RELAPSED/REFRACTORY TRBC1 POSITIVE SELECTED T CELL NON‐HODGKIN LYMPHOMA

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study

Compassion as a mediator between stressful events and perceived stress in Greek students

Compassion as a mediator between stressful events and perceived stress in Greek students

Lenalidomide for heavily pretreated relapsed/refractory myeloma cohort in northwest United Kingdom (UK) - efficacy & tolerability: high response & low second malignancy rates

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK

Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction

890MO Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR.T cell, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors — a Retrospective Study By the EBMT Chronic Malignancies Working Party

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder

Detection of IDH1 R132H mutation in acute myeloid leukemia by mutation-specific immunohistochemistry

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party

Immune reconstitution more than one year after allogeneic haematopoietic stem cell transplantation.(Early side effects/Late effects and quality life)

Suchergebnisse filtern